1 false false false false false false false true false false true false false false false false false No description of principal activity 2024-10-01 Sage Accounts Production Advanced 2025 - FRS102_2024 xbrli:pure xbrli:shares iso4217:GBP 10190309 2024-10-01 2025-09-30 10190309 2025-09-30 10190309 2024-09-30 10190309 2023-10-01 2024-09-30 10190309 2024-09-30 10190309 2023-09-30 10190309 bus:Director1 2024-10-01 2025-09-30 10190309 bus:Micro-entities 2024-10-01 2025-09-30 10190309 bus:AuditExemptWithAccountantsReport 2024-10-01 2025-09-30 10190309 bus:SmallCompaniesRegimeForAccounts 2024-10-01 2025-09-30 10190309 bus:PrivateLimitedCompanyLtd 2024-10-01 2025-09-30 10190309 bus:FullAccounts 2024-10-01 2025-09-30
COMPANY REGISTRATION NUMBER: 10190309

Topet Pharma UK Ltd

Unaudited financial statements

30 September 2025

Topet Pharma UK Ltd

Statement of financial position

30 September 2025

| 2025 | 2024
| £ | £ | £ | £
Current assets |  | 1 |  | 1

|  | ---- |  | ----
Net current assets |  | 1 |  | 1
|  | ---- |  | ----
Total assets less current liabilities |  | 1 |  | 1
|  | ---- |  | ----

Capital and reserves |  | 1 |  | 1
|  | ---- |  | ----

Notes to the financial statements
1. Employee numbers
The average number of employees during the year was 1 (2024: 1 ).
The company did not trade during the year and has not made either a profit or loss.
For the year ending 30 September 2025 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.
Director's responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the board of directors and authorised for issue on 18 March 2026 , and are signed on behalf of the board by:

J A Hancock |
Director |

Company registration number: 10190309
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Unit 2 Cavendish Road, Bury St Edmunds, Suffolk, IP33 3TE, England.